A phase I/II trial showed that transplanting dopaminergic progenitors derived from induced pluripotent stem cells was safe in Parkinson's disease, while a phase I trial of the human embryonic stem ...

The voices, values and lived experience of people living with dementia - and their families - must shape the path forward for ...

A group of expert neurologists have expressed concerns at the European Commission’s (EC) decision to formally approve the Alzheimer’s drug lecanemab (Leqembi) despite uncertain benefits. Lecanemab, ...